Craig C. Hopkinson

Insider Reports History

Location
Waltham, MA
Signature
/s/ Shantale Greenson, attorney-in-fact for Craig C. Hopkinson
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Craig C. Hopkinson:

Company Role Class Num Shares Value Price $ Report Date Ownership
Alkermes plc. EVP R&D, Chief Medical Officer Ordinary Shares 61,740 $1,852,261 $30.00 08 Jan 2026 Direct
ALBIREO PHARMA, INC. Director Common Stock 10,495 $459,681 $43.80 01 Dec 2022 Direct
Alkermes plc. EVP R&D, Chief Medical Officer Employee Stock Option (Right to Buy) 31,356 08 Jan 2026 Direct
Alkermes plc. EVP R&D, Chief Medical Officer Restricted Stock Unit Award 20,598 26 Feb 2025 Direct
ALBIREO PHARMA, INC. Director Restricted Stock Units 0 02 Mar 2023 Direct

Insider Reports Filed by Craig C. Hopkinson

Symbol Company Period Transactions Value $ Form Type Role Filing Time
ALKS Alkermes plc. 08 Jan 2026 3 -$53,305 4 EVP R&D, Chief Medical Officer 08 Jan 2026, 17:23
ALKS Alkermes plc. 02 Jan 2026 1 -$112,000 4 EVP R&D, Chief Medical Officer 02 Jan 2026, 16:39
ALKS Alkermes plc. 03 Dec 2025 3 -$39,961 4 EVP R&D, Chief Medical Officer 05 Dec 2025, 16:21
ALKS Alkermes plc. 01 Dec 2025 1 -$117,200 4 EVP R&D, Chief Medical Officer 01 Dec 2025, 17:41
ALKS Alkermes plc. 03 Nov 2025 3 -$176,742 4 EVP R&D, Chief Medical Officer 03 Nov 2025, 16:37
ALKS Alkermes plc. 15 Oct 2025 3 -$187,076 4 EVP R&D, Chief Medical Officer 15 Oct 2025, 18:47
ALKS Alkermes plc. 26 Feb 2025 3 -$106,090 4 EVP R&D, Chief Medical Officer 28 Feb 2025, 17:16
ALKS Alkermes plc. 22 Feb 2025 6 -$313,147 4 EVP R&D, Chief Medical Officer 25 Feb 2025, 18:35
ALKS Alkermes plc. 18 Feb 2025 5 -$141,805 4 EVP R&D, Chief Medical Officer 20 Feb 2025, 17:13
ALKS Alkermes plc. 12 Feb 2025 12 -$3,586,007 4 EVP R&D, Chief Medical Officer 14 Feb 2025, 17:12
ALKS Alkermes plc. 06 Feb 2025 2 -$473,455 4 EVP R&D, Chief Medical Officer 07 Feb 2025, 20:31
ALKS Alkermes plc. 30 Jan 2025 9 -$1,065,245 4 EVP R&D, Chief Medical Officer 31 Jan 2025, 20:42
ALKS Alkermes plc. 09 Dec 2024 9 -$849,147 4 EVP R&D, Chief Medical Officer 09 Dec 2024, 20:53
ALKS Alkermes plc. 05 Dec 2024 1 -$290,462 4 EVP R&D, Chief Medical Officer 05 Dec 2024, 18:01
ALKS Alkermes plc. 04 Dec 2024 1 -$441,550 4 EVP R&D, Chief Medical Officer 04 Dec 2024, 16:52
ALKS Alkermes plc. 11 Nov 2024 3 -$912,124 4 EVP R&D, Chief Medical Officer 12 Nov 2024, 16:48
ALKS Alkermes plc. 06 Nov 2024 1 -$309,169 4 EVP R&D, Chief Medical Officer 06 Nov 2024, 19:47
ALKS Alkermes plc. 23 Feb 2024 5 -$100,952 4 EVP R&D, Chief Medical Officer 27 Feb 2024, 16:03
ALKS Alkermes plc. 22 Feb 2024 3 -$157,617 4 EVP R&D, Chief Medical Officer 23 Feb 2024, 16:07
ALKS Alkermes plc. 18 Feb 2024 6 -$266,086 4 EVP R&D, Chief Medical Officer 21 Feb 2024, 17:32
ALKS Alkermes plc. 08 Feb 2024 13 +$101,155 4 EVP R&D, Chief Medical Officer 12 Feb 2024, 21:57
/report/000120919123014724-hopkinson-craig-c-2023-03-02 ALBIREO PHARMA, INC. 02 Mar 2023 1 $0 4 Director 02 Mar 2023, 15:39
ALKS Alkermes plc. 22 Feb 2023 5 -$148,431 4 EVP R&D, Chief Medical Officer 24 Feb 2023, 19:23
ALKS Alkermes plc. 18 Feb 2023 11 -$448,625 4 EVP R&D, Chief Medical Officer 22 Feb 2023, 15:56
/report/000120919122059710-hopkinson-craig-c-2022-12-01 ALBIREO PHARMA, INC. 01 Dec 2022 0 $0 3 Director 05 Dec 2022, 15:40
/report/000120919122059652-hopkinson-craig-c-2022-12-01 ALBIREO PHARMA, INC. 01 Dec 2022 1 $0 4 Director 05 Dec 2022, 15:10
ALKS Alkermes plc. 23 Feb 2022 1 -$296,650 4 EVP R&D, Chief Medical Officer 24 Feb 2022, 16:34
ALKS Alkermes plc. 18 Feb 2022 12 -$271,651 4 EVP R&D, Chief Medical Officer 23 Feb 2022, 15:40
ALKS Alkermes plc. 16 Feb 2022 3 -$28,639 4 EVP R&D, Chief Medical Officer 17 Feb 2022, 15:24
ALKS Alkermes plc. 14 Sep 2021 2 -$172,798 4 EVP R&D, Chief Medical Officer 16 Sep 2021, 16:25
ALKS Alkermes plc. 09 Jun 2021 1 -$21,697 4 EVP R&D, Chief Medical Officer 11 Jun 2021, 16:36
ALKS Alkermes plc. 07 Jun 2021 3 -$8,648 4 EVP R&D, Chief Medical Officer 08 Jun 2021, 18:51